Skip to content
by Legal Desire
23 December 2025

Latham & Watkins Advises on Fulgent Genetics’ Acquisition of Bako Diagnostics and StrataDX

Advising firms

Deal team

22 lawyers named
LawyerFirmSeniorityPracticeOffice
David Allinson Lead Latham & Watkins LLP Partner corporate New York
Edmond Parhami Lead Latham & Watkins LLP Partner corporate New York
Josh Barkow Latham & Watkins LLP Associate corporate Not stated
Samyung Han Latham & Watkins LLP Associate corporate Not stated
Matthew Dewitz Latham & Watkins LLP Partner tax New York
Jack Santoro Latham & Watkins LLP Associate tax Not stated
Bradd Williamson Latham & Watkins LLP Partner executive compensation, employment, and benefits New York
Max Raskin Latham & Watkins LLP Partner executive compensation, employment, and benefits New York
Anne Bracaglia Latham & Watkins LLP Associate executive compensation, employment, and benefits Not stated
Seokwon Lee Latham & Watkins LLP Associate executive compensation, employment, and benefits Not stated
Nineveh Alkhas Latham & Watkins LLP Partner labor Chicago
Jocelyn Wexler Latham & Watkins LLP Associate labor Not stated
Jason Caron Latham & Watkins LLP Partner healthcare Washington, D.C.
Yanyan Zhou Latham & Watkins LLP Associate healthcare Not stated
Danny Machado Latham & Watkins LLP Associate healthcare Not stated
Deborah Hinck Latham & Watkins LLP Associate intellectual property Not stated
Susana Santos Latham & Watkins LLP Associate intellectual property Not stated
Zachary Shufro Latham & Watkins LLP Associate intellectual property Not stated
Victoria Allen Latham & Watkins LLP Associate intellectual property Not stated
Heather Deixler Latham & Watkins LLP Partner data privacy and cybersecurity Bay Area
Chad Leiper Latham & Watkins LLP Associate data privacy and cybersecurity Houston
Harrison White Latham & Watkins LLP Partner insurance Los Angeles

19 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.

REGISTER FREE SIGN IN

Want co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.

Stated terms

Stated value
USD 55.5m (approximately US$55.5 million)
What the figure measures
Total transaction value
Client
Fulgent Genetics, Inc.Buy-side
Counterparties
Consonance Capital Partners (Other)
Bako Diagnostics (Sell-side)
StrataDx (Sell-side)